TG Therapeutics Inc (NASDAQ:TGTX) currently has a daily average trading volume of 2.67M but it saw 1784447 shares traded in last market. With a market cap of 6.08B USD, the company’s current market price of $38.32 came falling about -2.82 while comparing to the previous closing price of $39.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $46.48 and as low as $15.63.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the TD Cowen which initiated the stock as “Buy” in its note to investors issued on October 29, 2024, recommending a price target of $50 for it. Goldman upgraded its recommendation for the stock as a “Neutral” from “Sell” on August 02, 2023 while assigning a price target range of $16-$12. Jefferies issued its recommendations for the stock as it resumed the price target for the stock in the range of between $55 and $40.
Over the week, TGTX’s stock price is moving 3.47% up while it is 9.52% when we observe its performance for the past one month. Year-to-date it is 27.31% up and over the past year, the stock is showing an upside performance of 141.77%.
Currently, TG Therapeutics Inc’s total number of outstanding shares is 158.17M. Company’s return on investment (ROI) stands at 7.99% and return on equity (ROE) at 19.70%. It has a price to earnings ratio (P/E ratio) of 157.05 while having a 21.88 of forward P/E ratio. Stock’s beta reads 1.94. Stock has a price to book (P/B) ratio of 25.54 while price to sale or P/S ratio amounts to 15.74. Its return on asset (ROA) is 7.60% on average.
